Cargando…
CRISPR: a journey of gene-editing based medicine
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is one of the hallmark of biological tools, contemplated as a valid and hopeful alternatives to genome editing. Advancements in CRISPR-based technologies have empowered scientists with an editing kit that allows them to employ their k...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679360/ https://www.ncbi.nlm.nih.gov/pubmed/33094378 http://dx.doi.org/10.1007/s13258-020-01002-x |
_version_ | 1783612324940087296 |
---|---|
author | Golkar, Zhabiz |
author_facet | Golkar, Zhabiz |
author_sort | Golkar, Zhabiz |
collection | PubMed |
description | CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is one of the hallmark of biological tools, contemplated as a valid and hopeful alternatives to genome editing. Advancements in CRISPR-based technologies have empowered scientists with an editing kit that allows them to employ their knowledge for deleting, replacing and lately “Gene Surgery”, and provides unique control over genes in broad range of species, and presumably in humans. These fast-growing technologies have high strength and flexibility and are becoming an adaptable tool with implementations that are altering organism’s genome and easily used for chromatin manipulation. In addition to the popularity of CRISPR in genome engineering and modern biology, this major tool authorizes breakthrough discoveries and methodological advancements in science. As scientists are developing new types of experiments, some of the applications are raising questions about what CRISPR can enable. The results of evidence-based research strongly suggest that CRISPR is becoming a practical tool for genome-engineering and to create genetically modified eukaryotes, which is needed to establish guidelines on new regulatory concerns for scientific communities. |
format | Online Article Text |
id | pubmed-7679360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-76793602020-11-23 CRISPR: a journey of gene-editing based medicine Golkar, Zhabiz Genes Genomics Review CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is one of the hallmark of biological tools, contemplated as a valid and hopeful alternatives to genome editing. Advancements in CRISPR-based technologies have empowered scientists with an editing kit that allows them to employ their knowledge for deleting, replacing and lately “Gene Surgery”, and provides unique control over genes in broad range of species, and presumably in humans. These fast-growing technologies have high strength and flexibility and are becoming an adaptable tool with implementations that are altering organism’s genome and easily used for chromatin manipulation. In addition to the popularity of CRISPR in genome engineering and modern biology, this major tool authorizes breakthrough discoveries and methodological advancements in science. As scientists are developing new types of experiments, some of the applications are raising questions about what CRISPR can enable. The results of evidence-based research strongly suggest that CRISPR is becoming a practical tool for genome-engineering and to create genetically modified eukaryotes, which is needed to establish guidelines on new regulatory concerns for scientific communities. Springer Singapore 2020-10-22 2020 /pmc/articles/PMC7679360/ /pubmed/33094378 http://dx.doi.org/10.1007/s13258-020-01002-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Golkar, Zhabiz CRISPR: a journey of gene-editing based medicine |
title | CRISPR: a journey of gene-editing based medicine |
title_full | CRISPR: a journey of gene-editing based medicine |
title_fullStr | CRISPR: a journey of gene-editing based medicine |
title_full_unstemmed | CRISPR: a journey of gene-editing based medicine |
title_short | CRISPR: a journey of gene-editing based medicine |
title_sort | crispr: a journey of gene-editing based medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679360/ https://www.ncbi.nlm.nih.gov/pubmed/33094378 http://dx.doi.org/10.1007/s13258-020-01002-x |
work_keys_str_mv | AT golkarzhabiz crisprajourneyofgeneeditingbasedmedicine |